Steve Horvath On April 28, 2026, Professor Steve Horvath from UCLA and Altos Labs presented “Epigenetic Clocks as Dynamic Biomarkers of Aging, Intervention, and Mortality”.
Juan Carlos Izpisua Belmonte On April 28, 2026, Dr. Juan Carlos Izpisua Belmonte from Altos Laboratory presented “Restoring Cellular Identity and Reversing Disease through Partial Reprogramming.”
On March 26, 2026, Dr. Weisheng Chen, Founder and CEO of Leveragen, presented “Development of an Engineered Mouse Platform for Single-Domain Heavy-Chain Antibodies.”
On February 10, 2026, Professor Johan Auwerx from the École Polytechnique Fédérale de Lausanne (EPFL) presented “Genetic Mapping of Aging Metabolism: Targets and Transitions Across Species.”
Hesheng Liu and his team have found a key brain function network that’s disrupted by Parkinson’s disease, according to a study published today in Nature.
Professor Qing Lu of Cincinnati Children's Hospital Medical Center delivered a talk at Changping Laboratory on December 26, 2025, on the role of epigenetic reprogramming in brain repair and tumor formation.
On December 22, 2025, Professor John Rasko AO from Altos Labs presented “Gene & Cell Therapies: Translating biological discoveries to cures.” The presentation examined the evolution of genetic medicines and the translational pathways required to move benchside discoveries into clinical
Professor Bo Peng of Fudan University delivered a talk at Changping Laboratory on December 17, 2025, on the renewal mechanisms of microglia and new therapeutic approaches for neurological diseases.
Professor Jintai Yu of Huashan Hospital, Fudan University, delivered a talk at Changping Laboratory on December 16,2025, on big-data-driven precision medicine for neurodegenerative diseases.
Dr. Lijia Ma of Westlake University delivered a talk at Changping Laboratory on November 28, 2025, on delivery systems and payload structure modification technologies for next-generation in vivo gene and cell therapy.